«After years of collaboration with some of the world's
leading prostate cancer researchers and medical institutions who have studied the scientific and clinical benefits of phi, we are pleased that the test is now available to help physicians and patients with an elevated PSA test result, more accurately detect prostate cancer2,» said John Blackwood, senior vice president, Chemistry / Immunoassay Business Unit, Beckman Coulter Diagnostics.
Beer's team
of prostate cancer researchers at OHSU's Knight Cancer Institute have been involved in, or led, clinical trials for three of the five new treatments developed for prostate cancer in recent years.
Gene Markers Located for Hereditary
Prostate Cancer Researchers at the Johns Hopkins Brady Urological Institute, Wake Forest University and the Karolinska Institute in Sweden identified an array of gene markers for hereditary prostate cancer that, along with family history for the disease, appear to raise risk to more than nine times that of men without such markers.
The study «connects the dots in a very detailed way between macrophages and the hormone receptor signaling pathway,»
says prostate cancer researcher Charles Sawyers of the University of California, Los Angeles.
Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make - up of DNA, in about 50 % of patient tumour samples.